Literature DB >> 7665244

The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas.

V Kerekatte1, K Smiley, B Hu, A Smith, F Gelder, A De Benedetti.   

Abstract

The eukaryotic translation initiation factor eIF-4E binds to the cap structure of mRNAs as one component of the eIF-4 translation initiation complex, which mediates the recruitment of mRNA to the ribosomes. Overexpression of eIF-4E can result in oncogenic transformation and uncontrolled growth of mammalian cells, presumably by facilitating the expression of growth-control gene products which are normally translationally repressed. Whereas the mechanism of eIF-4E-mediated transformation is being actively pursued, clinical investigations into the expression of eIF-4E in prevalent human cancers are lacking. We have recently initiated a screen of breast carcinomas by probing with eIF-4E antiserum. Using Western blots, we have analyzed the level of eIF-4E in 38 carcinomas, 7 normal samples and 3 fibroadenomas. We found that eIF-4E was elevated 3- to 10-fold in virtually all the carcinomas we analyzed, but not in fibroadenomas. This analysis was also confirmed by immunohistological staining in situ, showing that overexpression of eIF-4E can be readily identified at the single-cell level. Our results suggest that an elevation of eIF-4E may be an essential component in the development of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665244     DOI: 10.1002/ijc.2910640107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  57 in total

1.  Biochemical characterisation of cap-poly(A) synergy in rabbit reticulocyte lysates: the eIF4G-PABP interaction increases the functional affinity of eIF4E for the capped mRNA 5'-end.

Authors:  A M Borman; Y M Michel; K M Kean
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Complex formation between potyvirus VPg and translation eukaryotic initiation factor 4E correlates with virus infectivity.

Authors:  S Léonard; D Plante; S Wittmann; N Daigneault; M G Fortin; J F Laliberté
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

4.  Up-regulation of expression of translation factors--a novel molecular mechanism for cadmium carcinogenesis.

Authors:  Pius Joseph; Yi-Xiong Lei; Tong-man Ong
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 5.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

6.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

7.  High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.

Authors:  Kiyotaka Mochizuki; Akihiro Oguro; Takashi Ohtsu; Nahum Sonenberg; Yoshikazu Nakamura
Journal:  RNA       Date:  2005-01       Impact factor: 4.942

8.  Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.

Authors:  W K Miskimins; G Wang; M Hawkinson; R Miskimins
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 9.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

10.  Novel Lobophorins Inhibit Oral Cancer Cell Growth and Induce Atf4- and Chop-Dependent Cell Death in Murine Fibroblasts.

Authors:  Patricia G Cruz; Andrew M Fribley; Justin R Miller; Martha J Larsen; Pamela J Schultz; Renju T Jacob; Giselle Tamayo-Castillo; Randal J Kaufman; David H Sherman
Journal:  ACS Med Chem Lett       Date:  2015-07-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.